Real-World test for endometriosis pain relief
NCT ID NCT07440043
Summary
This study aims to see how well a specific oral hormone therapy (relugolix combination therapy) works for reducing pelvic pain in women with endometriosis during routine medical care. It will follow about 33 women for 24 weeks to measure changes in their pain levels and other symptoms. The goal is to gather real-world evidence to help doctors make better treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.